Marissa R Shams1, Alice C Bruce2, Anne M Fitzpatrick3. 1. Emory University Department of Pediatrics, Atlanta, Ga; Emory University Department of Medicine, Atlanta, Ga. 2. Emory University Department of Pediatrics, Atlanta, Ga. 3. Emory University Department of Pediatrics, Atlanta, Ga. Electronic address: anne.fitzpatrick@emory.edu.
Abstract
BACKGROUND: The factors associated with poor asthma control, exacerbations, and health care utilization in black adolescents are complex and not well understood. Although psychological comorbidities such as anxiety are common in patients with asthma, these have not been studied in this population. OBJECTIVE: This study characterized anxiety and associated asthma features in a cohort of black inner-city adolescents with persistent asthma and determined the association between anxiety symptoms, persistent uncontrolled asthma, and prospective health care utilization over 1 year. METHODS: Eighty-six black adolescents were enrolled, phenotyped, and screened for anxiety symptoms with the Hospital Anxiety and Depression Scale anxiety subscale (HADS-A). Participants were telephoned every 2 months and a second study visit was completed at 1 year. Primary outcomes included persistent uncontrolled asthma, asthma exacerbations requiring systemic corticosteroids, and unscheduled health care utilization during the 1-year study period. RESULTS: A total of 31% (n = 27) of adolescents had probable anxiety (ie, HADS-A score >7) and 27% (n = 23) had possible anxiety (ie, HADS-A score 5-7) at the baseline visit. Anxiety symptoms were associated with poorer asthma control, more impaired quality of life, and more insomnia symptoms. Adolescents with probable anxiety disorders also had increased odds of persistent uncontrolled asthma and emergency department utilization, with no differences in physician visits or systemic corticosteroid receipt. CONCLUSIONS: Inner-city black adolescents with persistent asthma have a high prevalence of anxiety symptoms associated with poorer asthma control, impaired quality of life, insomnia, and increased prospective emergency department utilization for asthma. Routine screening for anxiety disorders may be useful in the clinical management of adolescents with asthma.
BACKGROUND: The factors associated with poor asthma control, exacerbations, and health care utilization in black adolescents are complex and not well understood. Although psychological comorbidities such as anxiety are common in patients with asthma, these have not been studied in this population. OBJECTIVE: This study characterized anxiety and associated asthma features in a cohort of black inner-city adolescents with persistent asthma and determined the association between anxiety symptoms, persistent uncontrolled asthma, and prospective health care utilization over 1 year. METHODS: Eighty-six black adolescents were enrolled, phenotyped, and screened for anxiety symptoms with the Hospital Anxiety and Depression Scale anxiety subscale (HADS-A). Participants were telephoned every 2 months and a second study visit was completed at 1 year. Primary outcomes included persistent uncontrolled asthma, asthma exacerbations requiring systemic corticosteroids, and unscheduled health care utilization during the 1-year study period. RESULTS: A total of 31% (n = 27) of adolescents had probable anxiety (ie, HADS-A score >7) and 27% (n = 23) had possible anxiety (ie, HADS-A score 5-7) at the baseline visit. Anxiety symptoms were associated with poorer asthma control, more impaired quality of life, and more insomnia symptoms. Adolescents with probable anxiety disorders also had increased odds of persistent uncontrolled asthma and emergency department utilization, with no differences in physician visits or systemic corticosteroid receipt. CONCLUSIONS: Inner-city black adolescents with persistent asthma have a high prevalence of anxiety symptoms associated with poorer asthma control, impaired quality of life, insomnia, and increased prospective emergency department utilization for asthma. Routine screening for anxiety disorders may be useful in the clinical management of adolescents with asthma.
Authors: Guilherme V Polanczyk; Giovanni A Salum; Luisa S Sugaya; Arthur Caye; Luis A Rohde Journal: J Child Psychol Psychiatry Date: 2015-02-03 Impact factor: 8.982
Authors: Giorgio Ciprandi; Irene Schiavetti; Elena Rindone; Fabio L M Ricciardolo Journal: Ann Allergy Asthma Immunol Date: 2015-09-29 Impact factor: 6.347
Authors: Karen E Wells; Sonia Cajigal; Edward L Peterson; Brian K Ahmedani; Rajesh Kumar; David E Lanfear; Esteban G Burchard; L Keoki Williams Journal: J Allergy Clin Immunol Date: 2016-03-22 Impact factor: 10.793
Authors: Alexandra L Quittner; Janice Abbott; Anna M Georgiopoulos; Lutz Goldbeck; Beth Smith; Sarah E Hempstead; Bruce Marshall; Kathryn A Sabadosa; Stuart Elborn Journal: Thorax Date: 2015-10-09 Impact factor: 9.139
Authors: Eleanor R Turi; Laura C Reigada; Jianfang Liu; Sarah I Leonard; Jean-Marie Bruzzese Journal: Ann Allergy Asthma Immunol Date: 2021-09-20 Impact factor: 6.347
Authors: Gustaf Rejnö; Cecilia Lundholm; Sara Öberg; Paul Lichtenstein; Henrik Larsson; Brian D'Onofrio; Kjell Larsson; Sissel Saltvedt; Bronwyn K Brew; Catarina Almqvist Journal: Sci Rep Date: 2019-09-11 Impact factor: 4.379
Authors: Delaney Griffiths; Lauren M Giancola; Kelly Welsh; Kristen MacGlashing; Christine Thayer; Sigfus Gunnlaugsson; Natalie P Stamatiadis; Gabriella C Sierra; Adam Hammond; Kimberly F Greco; Tregony Simoneau; Sachin N Baxi; Jonathan M Gaffin Journal: Pediatr Pulmonol Date: 2020-10-26
Authors: Peter G Gibson; Charlene M Prazma; Geoffrey L Chupp; Eric S Bradford; Mark Forshag; Stephen A Mallett; Steve W Yancey; Steven G Smith; Elisabeth H Bel Journal: Respir Res Date: 2021-06-07